Hospital-Based Tap Water Iontophoresis for Primary Focal Hyperhidrosis: A Real-World Analysis of Treatment Adherence, Efficacy, and Relapse

<b>Background:</b> Tap water iontophoresis (TWI) is a well-established second-line treatment for primary focal hyperhidrosis. While its efficacy is proven, data regarding the correlation between session frequency and clinical response, as well as long-term adherence in hospital-based settings, remain limited. <b>Objective:</b> We aimed to evaluate the efficacy and safety of hospital-based TWI and to analyze the relationship between the number of treatment sessions and clinical outcomes. <b>Methods:</b> This retrospective study included 92 patients with primary focal hyperhidrosis treated with TWI. Disease severity was assessed using the Hyperhidrosis Disease Severity Scale (HDSS). Clinical response was categorized as "Excellent" (≥2-point HDSS reduction), "Good" (1-point reduction), or "No Response." Relapse rates and reasons for treatment discontinuation were analyzed over a 6-month follow-up period. <b>Results:</b> The overall objective response rate was 65.2% (46.7% Excellent, 18.5% Good). A significant positive correlation was found between the total number of treatment sessions and the degree of clinical response (r = 0.401, <i>p</i> < 0.001). Patients achieving an "Excellent" response completed a significantly higher median number of sessions compared to non-responders (<i>p</i> = 0.001). However, among responders, the relapse rate was 85% within six months. Logistical difficulties were the most common reason for treatment discontinuation (17.5%). No compensatory hyperhidrosis or severe adverse events were observed. <b>Conclusions:</b> Hospital-based TWI is a safe and highly effective induction therapy, with success rates closely linked to the number of completed sessions. However, the high relapse rate and logistical barriers to adherence suggest that hospital-based protocols should serve primarily as a bridge to home-based maintenance therapy to ensure sustained long-term remission.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-01-13
DOI
https://doi.org/10.3390/jcm15020640
Primary Topic
Sympathectomy and Hyperhidrosis Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hospital-Based Tap Water Iontophoresis for Primary Focal Hyperhidrosis: A Real-World Analysis of Treatment Adherence, Efficacy, and Relapse

Berna Solak, Mizgin Gülmez
Journal of Clinical Medicine
Sympathectomy and Hyperhidrosis Treatments
article

Hospital-Based Tap Water Iontophoresis for Primary Focal Hyperhidrosis: A Real-World Analysis of Treatment Adherence, Efficacy, and Relapse

Berna Solak, Mizgin Gülmez
article en

Abstract

<b>Background:</b> Tap water iontophoresis (TWI) is a well-established second-line treatment for primary focal hyperhidrosis. While its efficacy is proven, data regarding the correlation between session frequency and clinical response, as well as long-term adherence in hospital-based settings, remain limited. <b>Objective:</b> We aimed to evaluate the efficacy and safety of hospital-based TWI and to analyze the relationship between the number of treatment sessions and clinical outcomes. <b>Methods:</b> This retrospective study included 92 patients with primary focal hyperhidrosis treated with TWI. Disease severity was assessed using the Hyperhidrosis Disease Severity Scale (HDSS). Clinical response was categorized as "Excellent" (≥2-point HDSS reduction), "Good" (1-point reduction), or "No Response." Relapse rates and reasons for treatment discontinuation were analyzed over a 6-month follow-up period. <b>Results:</b> The overall objective response rate was 65.2% (46.7% Excellent, 18.5% Good). A significant positive correlation was found between the total number of treatment sessions and the degree of clinical response (r = 0.401, <i>p</i> < 0.001). Patients achieving an "Excellent" response completed a significantly higher median number of sessions compared to non-responders (<i>p</i> = 0.001). However, among responders, the relapse rate was 85% within six months. Logistical difficulties were the most common reason for treatment discontinuation (17.5%). No compensatory hyperhidrosis or severe adverse events were observed. <b>Conclusions:</b> Hospital-based TWI is a safe and highly effective induction therapy, with success rates closely linked to the number of completed sessions. However, the high relapse rate and logistical barriers to adherence suggest that hospital-based protocols should serve primarily as a bridge to home-based maintenance therapy to ensure sustained long-term remission.

Journal of Clinical MedicineVol. 15(2)
Sakarya University (TR), Sakarya Eğitim ve Araştırma Hastanesi (TR)
Good health and well-being
Openalex Percentile: Top 89%
Sympathectomy and Hyperhidrosis Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.